Cite
Aussilhou B, Dokmak S, Faivre S, et al. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Ann Surg Oncol. 2009;16(6):1553-9doi: 10.1245/s10434-009-0447-z.
Aussilhou, B., Dokmak, S., Faivre, S., Paradis, V., Vilgrain, V., & Belghiti, J. (2009). Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Annals of surgical oncology, 16(6), 1553-9. https://doi.org/10.1245/s10434-009-0447-z
Aussilhou, Béatrice, et al. "Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab." Annals of surgical oncology vol. 16,6 (2009): 1553-9. doi: https://doi.org/10.1245/s10434-009-0447-z
Aussilhou B, Dokmak S, Faivre S, Paradis V, Vilgrain V, Belghiti J. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Ann Surg Oncol. 2009 Jun;16(6):1553-9. doi: 10.1245/s10434-009-0447-z. Epub 2009 Apr 11. PMID: 19363584.
Copy
Download .nbib